Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to Metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11): A randomized, open-label, multinational, phase 3b trial
It is unclear what these findings mean for changes in glycemic control in patients with type 2 diabetes mellitus
PlexusDx compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan) is available through a network of licensed 503A compounding pharmacies across all 50 states without insurance requirements
Reported side effects include skin rashes, abdominal pain (in rare instances), and temporary lightning in patches, which normalizes during treatment
Transcutaneous auricular vagus nerve stimulation mitigates gouty inflammation by reducing neutrophil infiltration in BALB/c mice